Global Retrospective Study Comparing Consolidation ALK Tyrosine Kinase Inhibitors (TKI) to Durvalumab (durva) or Observation (obs) after Chemoradiation (CRT) in Unresectable Locally-Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC).
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined